- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and...knowledge of the employees in the maintenance process, the information from SAP, the technical documentation and other data… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …practices.Develop positive relationships with the QA team, Quality Control, Information Technology , maintenance, Manufacturing personnel, Technical Operations ... we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …instructions.Develop positive relationship with the QA team, Quality Control, Information Technology , Maintenance, Manufacturing personnel, Technical Operations ... we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and...to complete tasks, knows how to get resources and information from established internal contacts; escalates to management when… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Tris Pharma (Knoxville, TN)
- …spanning neuroscience and other therapeutic categories employing our proprietary science and technology .Our science and technology make us unique, but our team ... providers (HCPs) and clients. This territory consists of Knoxville, Cookeville to Johnson City and the surrounding area. Qualified candidates must live within… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and commercialize ciltacabtagene… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and ... agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson , to jointly develop and...to complete tasks, knows how to get resources and information from established internal contacts; consult with supervisor for… more
